By ScienceDaily — 2021
Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a new study.
Read on www.sciencedaily.com
CLEAR ALL
You can recover from posttraumatic stress. Certainly, you can significantly reduce—not just manage—its symptoms. But—and here’s the thing—not with traditional treatment.
One of the most dramatic, butt-kicking examples of an effective new treatment tool for posttraumatic stress is a simple protocol called Nightmare Reprocessing, devised by two V.A. psychologists.
Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).
1
The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
How magic mushrooms expand consciousness.
2
This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.
The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.